BINEX Co., Ltd. (KOSDAQ: 053030)

Market Cap	616.94B
Revenue (ttm)	128.30B
Net Income (ttm)	-18.86B
Shares Out	30.92M
EPS (ttm)	-647.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,032,855
Open	21,300
Previous Close	20,750
Day's Range	19,720 - 21,750
52-Week Range	7,240 - 25,450
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 552
• Stock Exchange: KOSDAQ
• Ticker Symbol: 053030

Financial Performance

In 2023, BINEX's revenue was 154.82 billion, a decrease of -1.18% compared to the previous year's 156.68 billion. Earnings were 4.67 billion, a decrease of -62.47%.